Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is associated with immune dysfunction and an increased risk of melanoma. For patients with metastatic melanoma, immunotherapy with checkpoint blocking antibodies is a standard of care. In patients with concomitant CLL and metastatic melanoma, it is not known whethe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Immunother
Egile Nagusiak: Smithy, James W., Pianko, Matthew J., Maher, Colleen, Postow, Michael A., Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Wolchok, Jedd D., Park, Jae H., Callahan, Margaret K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727280/
https://ncbi.nlm.nih.gov/pubmed/33290361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000345
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak